LENSAR to Hold Third Quarter 2020 Financial Results and Business Update Conference Call on Monday, November 9, 2020
November 02 2020 - 8:00AM
Business Wire
LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a
global medical technology company focused on femtosecond laser
surgical solutions for the treatment of cataracts, today announced
that the Company’s third quarter 2020 financial results will be
released after market close on Monday, November 9, 2020. LENSAR’s
management will host a conference call and webcast at 4:30 p.m.
Eastern Time on Monday, November 9th to discuss the financial
results and recent corporate highlights.
To participate by telephone, please dial (866) 393-4306
(Domestic) or (734) 385-2616 (International). The conference ID
number is 3077696. To access the live webcast, please go to the
Events & Presentations section of LENSAR’s investor relations
website at https://ir.lensar.com. Following the live webcast, an
archived version of the call will be available on the website.
About LENSAR
LENSAR is a commercial-stage medical device company focused on
designing, developing and marketing an advanced femtosecond laser
system for the treatment of cataracts and the management of
pre-existing or surgically induced corneal astigmatism. Its LENSAR
Laser System incorporates a range of proprietary technologies
designed to assist the surgeon in obtaining better visual outcomes,
efficiency and reproducibility by providing advanced imaging,
simplified procedure planning, efficient design and
precision.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201102005140/en/
Thomas R. Staab, II, CFO ir.contact@lensar.com
Lee Roth / Cameron Radinovic Burns McClellan for LENSAR
lroth@burnsmc.com / cradinovic@burnsmc.com
LENSAR (NASDAQ:LNSR)
Historical Stock Chart
From Apr 2024 to May 2024
LENSAR (NASDAQ:LNSR)
Historical Stock Chart
From May 2023 to May 2024